Retatrutide, developed by Soma, represents a promising development in metabolic regulation. This innovative medication combines GLP-1 receptor properties with gut-derived receptor engagement, showing impressive results in patient findings for weight improvement. Scientists believe this treatment is expected to offer a alternative solution for patie